Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial
Declercq et al., The Lancet Respiratory Medicine, doi:10.1016/S2213-2600(21)00377-5
https://c19early.org/declercq.html